DK0655445T3 - Derivater af 1,3,4-oxiadiazol-2(3H)-on, deres fremstilling og deres anvendelse som inhibitorer af monoaminoxydase - Google Patents

Derivater af 1,3,4-oxiadiazol-2(3H)-on, deres fremstilling og deres anvendelse som inhibitorer af monoaminoxydase

Info

Publication number
DK0655445T3
DK0655445T3 DK94402642.6T DK94402642T DK0655445T3 DK 0655445 T3 DK0655445 T3 DK 0655445T3 DK 94402642 T DK94402642 T DK 94402642T DK 0655445 T3 DK0655445 T3 DK 0655445T3
Authority
DK
Denmark
Prior art keywords
group
alkoxy
derivatives
monoamine oxidase
oxyadiazole
Prior art date
Application number
DK94402642.6T
Other languages
Danish (da)
English (en)
Inventor
Samir Jegham
Jean-Jacques Koenig
Frederic Puech
Philippe Burnier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of DK0655445T3 publication Critical patent/DK0655445T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94402642.6T 1993-11-26 1994-11-21 Derivater af 1,3,4-oxiadiazol-2(3H)-on, deres fremstilling og deres anvendelse som inhibitorer af monoaminoxydase DK0655445T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9314151A FR2712886B1 (fr) 1993-11-26 1993-11-26 Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
DK0655445T3 true DK0655445T3 (da) 1998-03-23

Family

ID=9453245

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94402642.6T DK0655445T3 (da) 1993-11-26 1994-11-21 Derivater af 1,3,4-oxiadiazol-2(3H)-on, deres fremstilling og deres anvendelse som inhibitorer af monoaminoxydase

Country Status (24)

Country Link
US (1) US5525619A (cs)
EP (1) EP0655445B1 (cs)
JP (1) JPH07196636A (cs)
KR (1) KR950014088A (cs)
CN (1) CN1106395A (cs)
AT (1) ATE157356T1 (cs)
AU (1) AU679127B2 (cs)
CA (1) CA2136669A1 (cs)
CZ (1) CZ291794A3 (cs)
DE (1) DE69405198T2 (cs)
DK (1) DK0655445T3 (cs)
ES (1) ES2107157T3 (cs)
FI (1) FI945562A7 (cs)
FR (1) FR2712886B1 (cs)
GR (1) GR3025272T3 (cs)
HU (1) HUT71111A (cs)
IL (1) IL111769A (cs)
NO (1) NO944513L (cs)
NZ (1) NZ264991A (cs)
PL (1) PL305999A1 (cs)
RU (1) RU94042230A (cs)
SK (1) SK143594A3 (cs)
TW (1) TW284761B (cs)
ZA (1) ZA949394B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763068B1 (fr) * 1997-05-06 1999-06-04 Synthelabo Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2766485B1 (fr) * 1997-07-23 2002-05-24 Synthelabo Derives de 2,4-dihydro-3h-1,2,4-triazol-3-one, leur prparation et leur application en therapeutique
JP2001039954A (ja) * 1999-05-24 2001-02-13 Tomono Agrica Co Ltd ヘテロ環誘導体
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
CN104016939B (zh) * 2014-05-28 2016-06-15 浙江工业大学 一种2-亚乙基-3-乙酰基-1,3,4-噁二唑类化合物及其制备与应用
CN104016938B (zh) * 2014-05-28 2016-08-17 浙江工业大学 一种含苯硒基的噁二唑类化合物及其制备与应用
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631827B1 (fr) * 1988-05-27 1992-03-27 Delalande Sa Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique
JPH0366056A (ja) * 1989-08-03 1991-03-20 Matsushita Electric Ind Co Ltd 回転ヘッド装置
FR2655044B1 (fr) * 1989-11-24 1995-03-03 Delalande Sa Derives d'(hetero) arylmethyloxy-4 phenyl tetrazole et oxadiazole, leur procede de preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
DE69405198T2 (de) 1998-01-29
ATE157356T1 (de) 1997-09-15
GR3025272T3 (en) 1998-02-27
CA2136669A1 (en) 1995-05-27
SK143594A3 (en) 1995-06-07
EP0655445B1 (fr) 1997-08-27
PL305999A1 (en) 1995-05-29
TW284761B (cs) 1996-09-01
EP0655445A1 (fr) 1995-05-31
FI945562L (fi) 1995-05-27
NO944513D0 (no) 1994-11-25
IL111769A0 (en) 1995-01-24
US5525619A (en) 1996-06-11
NZ264991A (en) 1995-07-26
JPH07196636A (ja) 1995-08-01
FR2712886B1 (fr) 1996-01-05
RU94042230A (ru) 1996-11-20
IL111769A (en) 1999-04-11
HU9403393D0 (en) 1995-02-28
AU679127B2 (en) 1997-06-19
ES2107157T3 (es) 1997-11-16
KR950014088A (ko) 1995-06-15
FI945562A0 (fi) 1994-11-25
CN1106395A (zh) 1995-08-09
ZA949394B (en) 1995-09-07
HUT71111A (en) 1995-11-28
FR2712886A1 (fr) 1995-06-02
CZ291794A3 (en) 1995-07-12
FI945562A7 (fi) 1995-05-27
AU7903094A (en) 1995-06-01
NO944513L (no) 1995-05-29
DE69405198D1 (de) 1997-10-02

Similar Documents

Publication Publication Date Title
NO900071D0 (no) 2-aminopyrimidinonderivater.
DK185287A (da) 4h-1-benzopyran-4-on-derivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
HUP0100638A2 (hu) FP agonistákként alkalmazható aromás C16-C20-szubsztituált tetrahidroprosztaglandinok és ezeket tartalmazó gyógyszerkészítmények
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
NO944513D0 (no) Oksadiazolderivater, fremgangsmåte for deres fremstilling og anvendelse
DK0579614T3 (da) Imidazoacridiner og deres antineoplastiske anvendelse
GB8530602D0 (en) Heterocyclic compounds
DK0646578T3 (da) Phenylcarboxamidisoxazoler og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmace
ES2022448B3 (es) Composicion desinfectante para lentes de contacto blandas, que contienen una disolucion de peroxido de hidrogeno estabilizada.
GB8829593D0 (en) Novel compounds
AR009452A1 (es) Compuestos de dihalopropeno, los agentes insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos.
DK161787D0 (da) Asymmetriske esterderivater af 1,4-dihydropyridin-3,5-dicarboxylsyre
KR910009257A (ko) 이펜프로딜 및 그의 유도체를 유효성분으로 하는 정신병치료제
DK1192152T3 (da) Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse
GR3002594T3 (en) Aromatic thioethers
PT83506B (pt) Processo para a preparacao de n-oxidos de alfa, alfa-diaril-4-aril-4-hidroxi-1-piperidilbutanamida
DE68923231D1 (de) Antihypertensive 3-Piperidinylindazol-Derivate.
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
ES550995A0 (es) Procedimiento para la obtencion de furazanos sustituidos
DK47187A (da) Substituerede pyrrolidin-2-oner og salte deraf samt deres fremstilling og anvendelse
DK551487A (da) 1-hydroxyalkylxanthiner samt farmaceutiske praeparater med indhold af saadanne forbindelser
DK0826663T3 (da) Alkynylaminosyrederivater og deres anvendelse som farmaceutiske forbindelser
DK109483A (da) Substituerede azolylethyl-oximinoalkyl-ethere, deres fremstilling og anvendelse som fungicider